跳至主要内容
临床试验/NCT03712683
NCT03712683已完成不适用

Prevalence of Subclinical Hypothyroidism in Women With Unexplained Infertility and the Effect of Thyroxin on Pregnancy Rate

Hawler Medical University0 个研究点目标入组 168 人开始时间: 2016年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
168
主要终点
Pregnancy

研究概览

简要总结

Subclinical hypothyroidism(SCH) is the elevated thyroid stimulating hormone (TSH) with normal free Thyroxine levels and it is a mild or compensated form of primary hypothyroidism. It has been suggested that SCH is more prevalent in infertile women (especially in women with ovulatory disorders.Various rates of SCH was reported in infertile women in different populations

详细描述

Despite well-established recommendations on screening and treatment of overt hypothyroid in infertile women, there is a controversy regard the treatment of SCH in infertile women .

There are few published data on the prevalence of SCH and the outcome of treatment of SCH in infertile women, many were conducted during IVF cycles . Moreover there are inconsistent results in these studies being authors advised to treat SCH before IVF and some other articles find out no any benefit regarding treatment with Thyroxine in SCH

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 42 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Unexplained infertility
  • TSH more than 2.5 and normal T3,T4 levels
  • Negative for Anti-thyroid antibodies

排除标准

  • current history of overt hypo or hyperthyroidism
  • recurrent pregnancy loss
  • women having franked causes for infertility like tubal blockage, pelvic inflammatory disease, endometriosis , ,uterine factor
  • Ovarian dysfunction or decreased ovarian reserve
  • abnormal seminal fluid analysis or male factor

研究组 & 干预措施

Sub clinical hypothyroid women

Experimental

Levothyroxine sodium(Euthyrox 50µg and 25 µg MerckSerono) treatment was initiated and the women were followed in a combined clinic of endocrinologist and Gynecologist.

2.5 µg of Thyroxine daily was prescribed to women with TSH more than 2.5 mIU/L. Women with TSH more than 4mIU/L were given 50 µg daily . When pregnancy was confirmed Thyroxine was continued till 13 weeks gestation .

干预措施: Thyroxine (Drug)

结局指标

主要结局

Pregnancy

时间窗: 2 years

Pregnancy was confirmed using human chorionic gonadotropin hormone (hCG) estimation from blood

次要结局

  • Miscarriage rate(13 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ariana Jawad

Assistant Professor

Hawler Medical University

相似试验